← Back to Clinical Trials
Recruiting NCT06163300

NCT06163300 MRI Analysis and Degenerative Spine

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06163300
Status Recruiting
Phase
Sponsor Universidade Nova de Lisboa
Condition Spine Disease
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2024-01-01
Primary Completion 2024-09

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age 85 Years
Study Type OBSERVATIONAL
Interventions
MRI advanced techniques

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2024-01-01 with a primary completion date of 2024-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Analysis of MRI advanced techniques in degenerative spinal disease. The main questions it aims to answer are: * Can we assess microstructural integrity of compressed nerve roots in degenerative spinal disease * What are the image biomarkers affected by disease * How they evolve with disease progression and treatment

Eligibility Criteria

Inclusion Criteria: * Age between 50 and 85 years * Diagnosis of spinal disease by clinical and imagiological criteria * More than 3 months duration of disease * Ability to give consent * Fluent portuguese speaker Exclusion Criteria: * Previous spine surgery * Spinal instability * Neurological disease that might interfere with walking * Known orthopedic conditions that causes significant gait impairment * Dementia or development disorder with cognitive impairment * Inability to give consent

Contact & Investigator

Central Contact

Nuno A.R. Cristino, M.D.

✉ nuno.cristino.ext@nms.unl.pt

📞 +351919484946

Frequently Asked Questions

Who can join the NCT06163300 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Spine Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06163300 currently recruiting?

Yes, NCT06163300 is actively recruiting participants. Contact the research team at nuno.cristino.ext@nms.unl.pt for enrollment information.

Where is the NCT06163300 trial being conducted?

This trial is being conducted at Setúbal, Portugal.

Who is sponsoring the NCT06163300 clinical trial?

NCT06163300 is sponsored by Universidade Nova de Lisboa. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology